Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2015-11-01
Source
PubMed
DOI
10.1177/0269881115609019
PubMed
26442957
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:27 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01Connectedness as a mechanism of change in psilocybin-assisted cognitive behavioral therapy for major depressive disorder2026-10-14Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trial2026-10-11Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD2026-09-08Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework2026-08-12Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica2026-07-29Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption2026-04-30A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience2026-04-14Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies2026-03-31Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors2026-03-26A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations2026-02-28Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study2026-01-18Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy2026-01-12A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder2025-12-25A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience2025-11-30

Related papers

No close related records were found yet.